Handok Of S. Korea To Develop Cancer Drug For Spectrum Of U.S.
This article was originally published in PharmAsia News
Executive Summary
South Korea's Handok Pharmaceuticals has signed an agreement with U.S.-based Spectrum Pharmaceuticals to develop and bring to market the cancer drug apaziquone